Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)
First Claim
Patent Images
1. A compound having the formula S-(L)n-B, wherein S is a signal providing structural unit that provides a signal that can be detected in vivo or detected in vitro, L links S to B, B is an agent other than a peptide moiety that binds to LOX-1, and n is either 0 or 1.
1 Assignment
0 Petitions
Accused Products
Abstract
Embodiments of the present invention relates to compounds labeled with imaging agents that also are capable of binding lectin-like oxidized low-density lipoprotein (LOX-1). The labeled compounds are useful for the diagnosis and monitoring of diseases in which inflammation plays a role, such as various cardiovascular diseases including but not limited to atherosclerosis, vulnerable plaque, and coronary artery disease, as well as rheumatoid arthritis.
12 Citations
86 Claims
- 1. A compound having the formula S-(L)n-B, wherein S is a signal providing structural unit that provides a signal that can be detected in vivo or detected in vitro, L links S to B, B is an agent other than a peptide moiety that binds to LOX-1, and n is either 0 or 1.
-
30. The compound of claim 30, wherein the metal chelating agent is selected from the group consisting of DTPA, 1,4,7-triaza-cyclononane-N,N′
- ,N″
-triacetic acid (NOTA), p-bromoacetamido-benyl-tetraethylaminetetraacetic acid (TETA), 1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA), EDTA, CHXa.
- ,N″
- 41. A composition comprising a compound having the formula S-(L)n-B, formula S-(L)n-B, wherein S is a signal providing structural unit that provides a signal that can be detected in vivo or detected in vitro, L links S to B, B is an agent other than a peptide moiety that binds to LOX-1, and n is either 0 or 1.
Specification